查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571688

感染监测解决方案市场规模、份额、趋势分析报告：按组件、最终用途、地区、细分市场预测，2024-2030 年

Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Component (Services, Software), By End-use (Long Term Care Facilities, Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

感染监测解决方案市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球感染监测解决方案市场规模将达14.8亿美元，2024年至2030年复合年增长率为13.1%。

全球医疗保健环境的改善和医疗保健IT基础设施的进步预计将在市场的成长中发挥关键作用。医疗保健相关感染（HAI）盛行率的增加是推动市场的关键因素之一。

根据美国美国就发现了约 722,000 例医院感染。此外，根据加州公共卫生部 (CDPH) 的数据，2016 年，400 家急诊医院报告了 18,924 例 HAI 病例。此外，根据欧盟委员会（EC）公布的事实，欧盟（EU）约有25,000人死于抗生素抗药性细菌。如果目前的感染趋势持续到 2050 年，这一数字预计将增加到每年 1000 万。

不断增加的研究合作和政府倡议也刺激了市场成长。例如，2018 年 1 月，印度医学研究委员会 (ICMR) 与辉瑞签署了伙伴关係协议，以实施抗菌药物抗药性管理计画。目标是扩大印度的抗菌素抗药性监控网络。

感染监测解决方案市场报告亮点

  • 到2023年，软体产业将占据63.4%的主导市场占有率。使用基于网路的软体可以进行即时分析和各种设定。
  • 预计服务业将成为成长最快的行业，预测期内复合年增长率为 13.5%。
  • 到2023年，医院细分市场将占据79.3%的压倒性市场占有率。医疗保健机构购买力的提高、对追踪软体的需求增加以及熟练的医疗专业人员的可用性预计将有助于该行业的成长。
  • 长期照护机构预计将成为成长最快的领域，预测期内复合年增长率为 14.0%。
  • 2023年，北美感染监测解决方案市场将占全球份额的50.3%。
  • 欧洲感染监测解决方案市场正在快速成长，2023年全球份额将达到22.2%。这一增长可归因于医疗旅游的增加、慢性病的增加和COVID-19的爆发等因素，这些因素对市场的成长产生了重大影响。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球感染监测解决方案市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 感染监测解决方案市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 感染监测解决方案市场：成分估计与趋势分析

  • 细分仪表板
  • 感染监控解决方案市场：2023 年和 2030 年组件变化分析
  • 服务
  • 软体

第五章感染监测解决方案市场：最终用途估计与趋势分析

  • 细分仪表板
  • 感染监控解决方案市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 长期照护设施
  • 其他的

第六章感染监测解决方案市场：区域估计和趋势分析

  • 2023 年及 2030 年感染监测解决方案市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 南非

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Becton Dickinson and Company
    • Premier, Inc
    • Wolters Kluwer NV
    • Cerner Corporation（Oracle）
    • Clinisys
    • GOJO Industries, Inc
    • Baxter International Inc.
    • Vigilanz Corporation
    • Truven Health Analytics
    • RL Datix Ltd
简介目录
Product Code: GVR-2-68038-661-5

Infection Surveillance Solutions Market Growth & Trends:

The global infection surveillance solutions market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare-associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria. The figure is expected to increase to 10 million deaths per year if the current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, the Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed a partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up the AMR surveillance network in India.

Infection Surveillance Solutions Market Report Highlights:

  • The software segment dominated with a market share of 63.4% in 2023. The use of web-based software provides real-time analysis and different configurations.
  • The services segment is expected to be the fastest-growing segment with a CAGR of 13.5% during the forecast period.
  • The hospital segment dominated with a market share of 79.3% in 2023. High purchasing power by healthcare institutes, the growing need for tracking software, and the presence of skilled medical professionals are poised to contribute to the segment's growth.
  • Long-term care facilities are expected to be the fastest-growing segment with a CAGR of 14.0% during the forecast period.
  • North America infection surveillance solutions market accounted for a global share of 50.3% in 2023.
  • Europe's infection surveillance solutions market is fast-growing with a global share of 22.2% in 2023. The growth can be attributed to factors such as an increase in medical tourism, a rise in chronic diseases, and an outbreak of COVID-19 majorly played a role in influencing the market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Infection Surveillance Solutions Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Infection Surveillance Solutions Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Infection Surveillance Solutions Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infection Surveillance Solutions Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Services
    • 4.3.1. Maintenance and Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Consultation and Training Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Implementation Service Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1. On Premise Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Web Based Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infection Surveillance Solutions Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infection Surveillance Solutions Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030(USD Million)
  • 5.4. Long Term Care Facilities
    • 5.4.1. Long Term Care Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infection Surveillance Solutions Market: Regional Estimates & Trend Analysis

  • 6.1. Infection Surveillance Solutions Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Italy
      • 6.3.6.1. Italy Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Norway
      • 6.3.7.1. Norway Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Denmark Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Sweden Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Kuwait Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. South Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Becton Dickinson and Company
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Premier, Inc
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Wolters Kluwer N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Cerner Corporation (Oracle)
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Clinisys
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. GOJO Industries, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Baxter International Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Vigilanz Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Truven Health Analytics
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. RL Datix Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives